Vivos Therapeutics Inc. (VVOS)
5.19
0.13 (2.57%)
At close: Jan 15, 2025, 1:38 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -13.58M | -23.84M | -20.29M | -12.06M | -10.75M | -8.44M |
| Depreciation & Amortization | 621.00K | 669.00K | 733.00K | 717.87K | 751.23K | 610.67K |
| Stock-Based Compensation | n/a | 2.40M | 2.66M | 2.17M | 1.99M | 1.28M |
| Other Working Capital | 1.88M | 474.00K | -507.00K | 70.15K | 1.86M | 1.15M |
| Other Non-Cash Items | -1.85M | -518.00K | -9.00K | 3.92M | 83.07K | 364.34K |
| Deferred Income Tax | n/a | n/a | 1.14M | n/a | 60.34K | n/a |
| Change in Working Capital | 2.86M | 1.71M | 28.00K | -431.07K | 2.53M | 867.10K |
| Operating Cash Flow | -11.95M | -19.59M | -15.73M | -5.68M | -5.34M | -5.31M |
| Capital Expenditures | -803.00K | -924.00K | -2.40M | -120.25K | -175.60K | -1.25M |
| Acquisitions | n/a | n/a | -225.00K | n/a | 250.00K | 133.34K |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -924.00K | 13.00K | -120.25K | 11.82K | n/a |
| Investing Cash Flow | -853.00K | -924.00K | -2.61M | -120.25K | 86.22K | -1.12M |
| Debt Repayment | n/a | n/a | -25.00K | 1.19M | 3.73M | -88.24K |
| Common Stock Repurchased | n/a | n/a | -1.50M | -2.15M | -350.00K | -1.00M |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -1.08M | n/a | -3.74M | 56.86K | 388.61K | -1.01M |
| Financial Cash Flow | 10.92M | n/a | 24.17M | 23.54M | 4.47M | 5.25M |
| Net Cash Flow | -1.88M | -20.51M | 5.82M | 17.74M | -785.37K | -1.18M |
| Free Cash Flow | -12.75M | -20.51M | -18.13M | -5.80M | -5.52M | -6.56M |